RSNA 2019 News

Volpara to feature upgrades, partnerships at RSNA 2019

By staff writers
November 28, 2019

Breast imaging software developer Volpara Solutions plans to showcase its artificial intelligence (AI)-powered clinical-decision support platform for breast cancer screening and highlight two business partnerships at the RSNA 2019 meeting in Chicago.

The newly redesigned VolparaScorecard+ software is designed to enhance radiologists' access to three key patient risk insights: breast density assessment, an indication of suspicious findings in the mammogram, and lifetime risk of developing breast cancer.

Volpara also will show its Volpara Live system, which automatically analyzes patient positioning and compression and provides immediate feedback to technologists on whether to retake images before a patient leaves the imaging session.

In other company news, Volpara Solutions is teaming with Dutch women's imaging software developer ScreenPoint Medical and MRS Systems, a provider of patient tracking, communication, and radiology reporting software for breast and lung imaging applications, to bring clinical decision-support tools to radiologists for screening for early detection of breast cancer.

Volpara expands medical advisory board
Breast imaging software developer Volpara Solutions has expanded its medical advisory board.
Volpara joins forces with ScreenPoint Medical
Following up on a previously announced memorandum of understanding, breast imaging software developer Volpara Solutions has finalized a distribution agreement...
Volpara inks deal to buy MRS Systems
Volpara Health Technologies, the parent company of breast imaging software developer Volpara Solutions, has signed a binding agreement to purchase MRS...
Volpara promotes study on stratifying breast cancer risk
Breast imaging software developer Volpara Solutions is highlighting a study published online May 11 in the Journal of Breast Imaging that combined...
Volpara software awarded certification
Breast imaging software developer Volpara Solutions has received Medical Device Single Audit Program (MDSAP) 690110 certification for the U.S., Canada,...

Copyright © 2019